MOAG-4 (modifier of aggregation 4) was found in a forward genetic screen using C. elegans models for neurodegenerative diseases, as an enhancer of aggregation and toxicity of several aggregation-prone disease proteins, including polyQ, α-synuclein, and Aβ (van Ham et al., 2010). Here, SNCA is linked to neurodegenerative disease.